A new study published in the British Medical Journal concluded that women previously treated for abnormal cells on the cervix (CIN3 or cervical intraepithelial neoplasis grade 3) are at increased risk of developing and dying from cervical or vaginal cancer compared with the general female population and that the risk rises after age 60. This is the first study to evaluate the risk of death from cervical cancer after treatment of CIN3) as women...